The bureaucratic bloat in federal research funding is finally facing a long-overdue reckoning, especially for indirect ...

A group of former leaders from health comms giant Inizio Evoke have come together to launch Flex Marketing, a new agency ...

Lake Street analyst Thomas Flaten maintained a Buy rating on Evaxion Biotech (EVAX – Research Report) today and set a price target of $6.00.

Evaxion Biotech (EVAX) has received confirmation from the Nasdaq Stock Market that it has re-established compliance with Nasdaq’s minimum ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

The "Project Management for Non-Project Managers - PM in the Life Sciences - Pharmaceutical/Biotechnology and Medical Devices" training has been added to ResearchAndMarkets.com's offering. What do you ...

As many as 40% of Americans are obese, putting them at an increased risk for high blood pressure, diabetes, stroke, heart disease and certain cancers, according to the CDC.

Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Republican Vivek Ramaswamy will launch his bid for Ohio governor on Feb. 24 in his native Cincinnati, with ensuing events in ...